Emily Wang is the Director of USMA Strategic Execution at Gilead Sciences, specializing in medical affairs strategy and operations. Her career includes key roles at Merck and ZS. Emily holds a Masters degree from Rutgers University and a Bachelors degree from Princeton University, underpinning her expertise in the pharmaceutical sector.
She transitioned from a foundational role in healthcare consulting at ZS to senior strategic positions at major pharmaceutical companies.
Read the full overview →Explore more public profiles from related professionals.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.